Bremer K, Fliedner T M
Biomedicine. 1975 Sep;22(5):404-10.
Autotransfusion of 3H-cytidine labeled blood lymphocytes was performed in 4 normal subjects, 3 patients with non-leukemic malignant lymphoma (1 reticulum cell sarcoma, 2 lymphosarcoma), 2 treated, non-leukemic patients with chronic lymphocytic leukemia (CLL) and 11 untreated CLL patients. Immediately after autotransfusion on the average only 41.3% and 47.5% of the infused labeled lymphocytes were recovered in the blood of the normal subjects and of the untreated CLL patients, respectively. During the first hour, in the normal subjects a higher proportion of labeled cells disappeared from the blood that in untreated CLL patients. Thereafter, this initial rapid decrease ceased and levelled off into a plateau with rather constant recovery values. At this time (1-4 hours after autotransfusion), on the average only 6.7% of the normal lymphocytes, but 27.8% of the untreated CLL lymphocytes were recovered in the blood. In the non-leukemic lymphoma of the untreated CLL lymphocytes were recovered in the blood. In the non-leukemic lymphoma patients and treated CLL patients the autotransfused lymphocytes exhibited circulation kinetics similar to those of the normal lymphocytes. The majority of blood lymphocytes from untreated patients with CLL seem to be characterized by a poor exchange rate between intra- and extravascular lymphocyte pools and a prolonged intra-vascular life span. These findings agree with the impaired recirculation kinetics of CLL lymphocytes and their abnormal 0ehaviour in several "in vitro" tests dealing with other lymphocyte functions.
对4名正常受试者、3名非白血病性恶性淋巴瘤患者(1例网状细胞肉瘤、2例淋巴肉瘤)、2例接受过治疗的非白血病性慢性淋巴细胞白血病(CLL)患者以及11例未经治疗的CLL患者进行了3H-胞苷标记的血液淋巴细胞自体输血。自体输血后,平均而言,正常受试者和未经治疗的CLL患者血液中分别仅回收到41.3%和47.5%的输注标记淋巴细胞。在最初的一小时内,正常受试者血液中标记细胞消失的比例高于未经治疗的CLL患者。此后,这种最初的快速下降停止,并趋于平稳,恢复值相当恒定。此时(自体输血后1 - 4小时),血液中平均仅回收到6.7%的正常淋巴细胞,但未经治疗的CLL淋巴细胞为27.8%。在非白血病性淋巴瘤患者和接受过治疗的CLL患者中,自体输血的淋巴细胞表现出与正常淋巴细胞相似的循环动力学。未经治疗的CLL患者的大多数血液淋巴细胞似乎具有血管内和血管外淋巴细胞池之间交换率低以及血管内寿命延长的特征。这些发现与CLL淋巴细胞循环动力学受损及其在涉及其他淋巴细胞功能的几种“体外”试验中的异常行为一致。